Shaoying Yang

606 total citations
20 papers, 138 citations indexed

About

Shaoying Yang is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Shaoying Yang has authored 20 papers receiving a total of 138 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Shaoying Yang's work include Diabetes and associated disorders (6 papers), T-cell and B-cell Immunology (5 papers) and Systemic Lupus Erythematosus Research (3 papers). Shaoying Yang is often cited by papers focused on Diabetes and associated disorders (6 papers), T-cell and B-cell Immunology (5 papers) and Systemic Lupus Erythematosus Research (3 papers). Shaoying Yang collaborates with scholars based in China, United States and South Korea. Shaoying Yang's co-authors include Liangjing Lu, Xiaomei Zhang, Chun‐Ming Pan, Zhaohui Gu, Liqiong Xue, Huai‐Dong Song, Guoyue Yuan, Guan-Qi Gao, Jun Liang and Wei Liu and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Shaoying Yang

15 papers receiving 137 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaoying Yang China 9 49 45 38 31 26 20 138
Leire Egia‐Mendikute Spain 7 32 0.7× 36 0.8× 14 0.4× 42 1.4× 17 0.7× 11 137
Rodney Pollard Netherlands 6 44 0.9× 62 1.4× 25 0.7× 54 1.7× 7 0.3× 6 332
Sarah Núñez Chile 8 21 0.4× 143 3.2× 16 0.4× 32 1.0× 5 0.2× 11 226
Perrine Cufi France 8 15 0.3× 108 2.4× 103 2.7× 29 0.9× 10 0.4× 8 425
Roald Omdal Sweden 6 50 1.0× 56 1.2× 27 0.7× 20 0.6× 2 0.1× 6 186
John A. Ice United States 6 56 1.1× 93 2.1× 8 0.2× 42 1.4× 8 0.3× 13 241
P Bignell United Kingdom 7 83 1.7× 24 0.5× 12 0.3× 38 1.2× 93 3.6× 15 285
Bernhard Fahrner Austria 5 35 0.7× 23 0.5× 11 0.3× 50 1.6× 11 0.4× 7 236
Karina Meden Sørensen Denmark 7 60 1.2× 21 0.5× 17 0.4× 107 3.5× 13 0.5× 9 185
Taba Kheradmand United States 9 50 1.0× 184 4.1× 20 0.5× 61 2.0× 14 0.5× 14 321

Countries citing papers authored by Shaoying Yang

Since Specialization
Citations

This map shows the geographic impact of Shaoying Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoying Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoying Yang more than expected).

Fields of papers citing papers by Shaoying Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaoying Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoying Yang. The network helps show where Shaoying Yang may publish in the future.

Co-authorship network of co-authors of Shaoying Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shaoying Yang. A scholar is included among the top collaborators of Shaoying Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaoying Yang. Shaoying Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Haiting, Shaoying Yang, Huihua Ding, et al.. (2025). Rituximab as the first-line treatment in newly diagnosed systemic lupus erythematosus. Frontiers in Immunology. 16. 1599473–1599473. 2 indexed citations
3.
Ji, Juan, Shaoying Yang, Yongxin Xu, et al.. (2025). M2-ApoBDs as a therapeutic strategy for systemic lupus erythematosus: targeted macrophage reprogramming and treg differentiation. Journal of Nanobiotechnology. 23(1). 354–354.
4.
5.
Xiao, Cheng, Yu Liu, Shaoying Yang, et al.. (2024). The comparison of meat yield, quality, and flavor between small-tailed Han sheep and two crossbred sheep and the verification of related candidate genes. Frontiers in Nutrition. 11. 1399390–1399390. 6 indexed citations
6.
Lin, Wanyi, et al.. (2024). Blau syndrome presenting as lipoma arborescens. The Lancet Rheumatology. 7(1). e72–e72.
7.
Zhang, Le, Jun Li, Yuan Li, et al.. (2023). Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study. Annals of the Rheumatic Diseases. 82(5). 722–724. 18 indexed citations
8.
Yang, Shaoying, et al.. (2023). A biomimetic adipocyte mesenchymal stem cell membrane-encapsulated drug delivery system for the treatment of rheumatoid arthritis. Nano Research. 16(8). 11401–11410. 10 indexed citations
9.
Yang, Shaoying, et al.. (2022). Palmar-plantar erythrodysesthesia in lupus during pregnancy. QJM. 115(6). 417–419.
10.
Zhang, Le, Shaoying Yang, Yongfu Yu, et al.. (2022). Prophylactic effect of tenofovir on viral reactivation in immunocompromised pregnant women living with hepatitis B virus. Hepatology Communications. 6(9). 2431–2440. 2 indexed citations
11.
Li­, ­Jun, Mi Zhou, Jiaqi Feng, et al.. (2022). Bulk RNA Sequencing With Integrated Single-Cell RNA Sequencing Identifies BCL2A1 as a Potential Diagnostic and Prognostic Biomarker for Sepsis. Frontiers in Public Health. 10. 937303–937303. 8 indexed citations
12.
Jiang, He, Feifei Yuan, Haining Wang, et al.. (2021). Compelling Evidence Linking CD40 Gene With Graves’ Disease in the Chinese Han Population. Frontiers in Endocrinology. 12. 759597–759597. 1 indexed citations
13.
14.
Zhao, Shuang‐Xia, Wei Liu, Ming Zhan, et al.. (2013). A Refined Study of FCRL Genes from a Genome-Wide Association Study for Graves’ Disease. PLoS ONE. 8(3). e57758–e57758. 23 indexed citations
15.
Liu, Bingli, Shaoying Yang, Wei Liu, et al.. (2013). Refined association of TSH receptor susceptibility locus to Graves' disease in the Chinese Han population. European Journal of Endocrinology. 170(1). 109–119. 11 indexed citations
16.
Xue, Liqiong, Chun‐Ming Pan, Zhaohui Gu, et al.. (2013). Genetic Heterogeneity of Susceptibility Gene in Different Ethnic Populations: Refining Association Study of PTPN22 for Graves’ Disease in a Chinese Han Population. PLoS ONE. 8(12). e84514–e84514. 13 indexed citations
17.
Liu, Wei, Haining Wang, Zhaohui Gu, et al.. (2013). Identification of BACH2 as a susceptibility gene for Graves’ disease in the Chinese Han population based on a three-stage genome-wide association study. Human Genetics. 133(5). 661–671. 18 indexed citations
18.
Song, Zhiyi, Wei Liu, Liqiong Xue, et al.. (2012). Dense mapping of IL2RA shows no association with Graves' disease in Chinese Han population. Clinical Endocrinology. 79(2). 267–274. 8 indexed citations
19.
Yang, Shaoying, Wei Liu, Liqiong Xue, et al.. (2011). Association of TSHR gene intron 1 polymorphisms with Graves′ disease. Zhonghua neifenmi daixie zazhi. 27(6). 478–481. 2 indexed citations
20.
Jiang, He, et al.. (2011). The mechanism of mimecan transcription induced by glucocorticoid in pituitary corticotroph cells. Molecular and Cellular Biochemistry. 360(1-2). 321–328. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leire Egia‐Mendikute Breakdown of academic impact, for papers by Rodney Pollard Breakdown of academic impact, for papers by Sarah Núñez Breakdown of academic impact, for papers by Perrine Cufi Breakdown of academic impact, for papers by Roald Omdal Breakdown of academic impact, for papers by John A. Ice Breakdown of academic impact, for papers by P Bignell Breakdown of academic impact, for papers by Bernhard Fahrner Breakdown of academic impact, for papers by Karina Meden Sørensen Breakdown of academic impact, for papers by Taba Kheradmand
Rankless by CCL
2026